万维提示：
1、投稿方式：在线投稿。
2、官网网址：https://onlinelibrary.wiley.com/journal/10981136
3、官网网址：http://mc.manuscriptcentral.com/glia/
4、官网邮箱：glia.berlin@mdc-berlin.de（编辑部）
brransom@cityu.edu.hk（主编）
glia.berlin@mdc-berlin.de（主编）
5、官网电话：+852 3442 4049（主编）
+49 30-9406-3325（主编）
6、期刊刊期：月刊，一个月出版一期。
2021年4月23日星期五
投稿须知
【官网信息】
AUTHOR GUIDELINES
1. SUBMISSION
Authors should kindly note that submission implies that the content has not been published or submitted for publication elsewhere except as a brief abstract in the proceedings of a scientific meeting or symposium.
GLIA will consider submissions that have previously been made available online, either on a preprint server like arXiv, bioRxiv, or PeerJ PrePrints, or on the authors’ own website. However, any such submissions must not have been published in a scientific journal, book or other venue that could be considered formal publication. Authors must inform the editorial office at submission if their paper has been made available as a preprint.
Authors of accepted papers that were made available as preprints must be able to assign copyright to GLIA, or agree to the terms of the Wiley Open Access agreement and pay the associated fee
Given that the measurable impact of the article is diminished when citations are split between the preprint and the published article, authors are required to:
Update the entry on the preprint server so that it links to and cites the DOI for the published version
Cite only the published article themselves
Once the submission materials have been prepared in accordance with the Author Guidelines, manuscripts should be submitted online via the journal's ScholarOne site: mc.manuscriptcentral.com/glia. For more details on how to use ScholarOne, visit www.wileyauthors.com/scholarone. Note, this journal uses iThenticate’s CrossCheck software to detect instances of overlapping and similar text in submitted manuscripts.
The submission system will prompt authors to use an ORCID iD (a unique author identifier) to help distinguish their work from that of other researchers. Click here to find out more.
By submitting a manuscript to or reviewing for this publication, your name, email address, and affiliation, and other contact details the publication might require, will be used for the regular operations of the publication, including, when necessary, sharing with the publisher (Wiley) and partners for production and publication. The publication and the publisher recognize the importance of protecting the personal information collected from users in the operation of these services, and have practices in place to ensure that steps are taken to maintain the security, integrity, and privacy of the personal data collected and processed. You can learn more at https://authorservices.wiley.com/statements/data-protection-policy.html.
For help with submissions, please contact the Editorial Office: glia@u.washington.edu and glia.berlin@mdc-berlin.de. When necessary, the Editorial Office staff may refer questions to the Editors-in-Chief.
2. AIMS AND SCOPE
GLIA is a peer-reviewed journal, which publishes articles dealing with all aspects of glial structure and function. This includes all aspects of glial cell biology in health and disease.
Launched in 1988, GLIA quickly rose to its current position as the number one journal in glial research. The journal publishes both original research articles and critical review papers; authors interested in contributing a review-type article should contact the Editorial Office to discuss the scope of the proposed article with the Editors-in-Chief.
In addition to regular issues, the journal also publishes Special Issues on hot topics within glial research, or assembles collections of related published papers in Virtual Issues. Visit the dedicated webpage to browse past Special and Virtual Issues of GLIA.
3. MANUSCRIPT CATEGORIES AND REQUIREMENTS
GLIA publishes the following contribution types:
Original Research Articles
Review Articles
Manuscripts should be prepared according to the descriptions below. Submissions that do not conform to the relevant descriptions below may be returned to the author. Authors are encouraged to make use of the “Resources for Writing Your Paper” section of www.wileyauthors.com/prepare when preparing their manuscript for submission; resources include blog posts on writing an effective abstract and the importance of a well-written introduction.
1) Original Research Articles
The manuscript should contain a 250-word abstract, and the main text should contain the following sections in this order: Introduction, Materials and Methods, Results, Discussion (i.e., follow the IMRaD guidelines). The literature review should be succint. There are no restrictions on the number of pages or figures.
2) Review Articles
Review Articles in which a specific field is reviewed through an exhaustive literature survey. The manuscript should contain a 250-word abstract. A Materials and Methods section and a Results section are not required. There are no restrictions on the number of pages or figures. Review articles are usually invited, but unsolicited Review Articles submitted to the journal of an appropriate quality will be considered for publication.
4. PREPARING THE SUBMISSION
Parts of the Manuscript
The submission should be uploaded in separate files: 1) manuscript main text file; 2) individual figure files; 3) Supporting information file(s); 4) Additional files.
1) Main Text File
The text file should be presented in the following order:
A short informative containing the major key words. The title should not contain abbreviations (see Wiley's best practice SEO tips);
A short running title of less than 40 characters;
The full names of the authors;
The author's institutional affiliations where the work was conducted, with a footnote for an author’s present address if different from where the work was conducted;
Acknowledgments;
Word Count
Abstract and keywords;
Table of Contents Image;
Main Points;
Main text;
References;
Tables (each table complete with title and footnotes);
Figure legends;
Title
The title should be short and informative, containing major keywords related to the content. The title should not contain abbreviations (see Wiley's best practice SEO tips).
Authorship
Please refer to the journal’s Authorship policy in the Editorial Policies and Ethical Considerations section for details on author listing eligibility.
Acknowledgments
Contributions from anyone who does not meet the criteria for authorship should be listed, with permission from the contributor, in an Acknowledgments section. Financial and material support should also be mentioned. Thanks to anonymous reviewers are not appropriate.
Conflict of Interest Statement
Authors will be asked to provide a Conflict of Interest statement during the submission process. For details on what to include in this section, see the Conflict of Interest section in the Editorial Policies and Ethical Considerations section below. Submitting authors should ensure they liaise with all co-authors to confirm agreement with the final statement.
Word Count
Authors are ask to provide the total word count of their manuscript on the title page of their submission, as well as the word count for each section of the manuscript.
Abstract
Authors should provide an abstract of 250 words or less that will serve in lieu of a concluding summary. The abstract must be written in complete sentences and succinctly state the objectives, experimental design of the paper, principal observations, and conclusions; it should be intelligible without reference to the rest of the paper. The Abstract should include relevant keywords (see below) to drive search engine optimization (SEO).
Keywords
Please provide five to seven keywords. To ensure search engine optimization (SEO), keywords should be chosen carefully and used appropriately throughout the manuscript (see Wiley's best practice SEO tips).
Table of Contents
The table of contents entry for each article published in GLIA comprises of main points and an accompanying graphic:
Main Points are the most important findings and/or conclusions of the article (or review), stated concisely. Main Points will be displayed online immediately below the article's title (they will not appear in the printed version of the paper). Main Points should consist of 2 to 3 short sentences and should not exceed 250 characters (including spaces). These are required for all papers published in GLIA.
Table of Contents Image (TOCI) is a summary graphic that appears in the online table of contents and in Early View articles. It is intended to illustrate and complement the Main Points. We strongly recommend submission of a TOCI but it is not mandatory. Authors should ideally upload the TOCI at the point of submission.
TOCI requirements:
Resolution: 300 d.p.i. for color/half tone and 800 d.p.i. for line work
File format: .tiff/.tif or .eps
Dimensions: 2.25 in / 5.7 cm / 215 pixels (width) by 2 in / 5 cm / 192 pixels (height)
Main Text
Manuscripts reporting original research should follow the IMRaD guidelines (Introduction, Methods, Results, and Discussion), which are recommended by the International Committee of Medical Journal Editors (ICMJE) (J. Pharmacol. Pharmacother. 2010, 1, 42–58).
Language: Authors for whom English is a second language are encouraged to seek assistance from a native English speaker prior to submission to optimize expression; alternatively, authors can employ a professional service such as the Wiley Editing Services. All authors should take care to polish their draft manuscript to address any typographical errors prior to submission.
Spelling: The journal uses US spelling.
Footnotes to the text are not allowed and any such material should be incorporated into the text as parenthetical matter.
Abbreviations: In general, terms should not be abbreviated unless they are used repeatedly and the abbreviation is helpful to the reader. Initially, use the word or phrase in full, followed by the abbreviation in parentheses. Thereafter use the abbreviation only. The title should NOT include any abbreviations unless widely understood. Abbreviations may be used in the Abstract, but must be defined in the first instance.
Units of measurement: Measurements should be given in SI or SI-derived units. Visit the Bureau International des Poids et Mesures (BIPM) website at www.bipm.fr for more information about SI units.
Numbers: numbers under 10 are spelt out, except for: measurements with a unit (8 mmol/L); age (6 weeks old), or lists with other numbers (11 dogs, 9 cats, 4 gerbils).
Trade Names: Chemical substances should be referred to by the generic name only. Trade names should not be used. Drugs should be referred to by their generic names. If proprietary drugs have been used in the study, refer to these by their generic name, mentioning the proprietary name and the name and location of the manufacturer in parentheses.
Species Names: Upon its first use in the title, abstract, and text, the common name of a species should be followed by the scientific name (genus, species, and authority) in parentheses. For well-known species, however, scientific names may be omitted from article titles. If no common name exists in English, only the scientific name should be used.
Genetic Nomenclature: Sequence variants should be described in the text and tables using both DNA and protein designations whenever appropriate. Sequence variant nomenclature must follow the current HGVS guidelines; see varnomen.hgvs.org, where examples of acceptable nomenclature are provided.
References
References should be prepared according to the Publication Manual of the American Psychological Association (6th edition). The APA website includes a range of resources for authors learning to write in APA style, including an overview of the manual, free tutorials on APA Style basics, and an APA Style Blog. For more information about APA referencing style, please also refer to the APA FAQ.
Endnote users can download the style here.
According to APA style, in text citations should follow the author-date method whereby the author's last name and the year of publication for the source should appear in the text, for example, (Jones, 1998). The complete reference list should appear alphabetically by name at the end of the paper.
A sample of the most common entries in reference lists appears below.
Authors should note that the APA referencing style requires that a Digital Object Identifier (DOI) be provided for all references where available. Also, for journal articles, issue numbers are not included unless each issue in the volume begins with page one.
Journal article
Beers, S. R., & De Bellis, M. D. (2002). Neuropsychological function in children with maltreatment-related posttraumatic stress disorder. The American Journal of Psychiatry, 159, 483– 486. doi: 10.1176/appi.ajp.159.3.483.
Book
Bradley-Johnson, S. (1994). Psychoeducational assessment of students who are visually impaired or blind: Infancy through high school (2nd ed.). Austin, TX: Pro-ed.
Internet Document
Norton, R. (2006, November 4). How to train a cat to operate a light switch [Video file]. Retrieved from www.youtube.com/watch?v=Vja83KLQXZs.
Tables
Tables should be self-contained and complement, not duplicate, information contained in the text. They should be supplied in an editable format (i.e., created in Microsoft Word and presented in the manuscript file), not pasted as images. Each Table should have a concise title, and concise but comprehensive footnotes. The table, including the title and footnotes, must be understandable without reference to the text. All abbreviations must be defined. Footnote symbols: †, ‡, §, ¶, should be used (in that order) and *, **, *** should be reserved for P-values. Statistical measures such as SD or SEM should be identified in the column heading(s) or where appropriate. Tables should be numbered with Arabic numerals in order of appearance in the text.
Figure Legends
Legends should be concise but comprehensive—the figure and its legend must be understandable without reference to the text. Include definitions of any symbols used and define/explain all abbreviations and units of measurement. Figures should be numbered with Arabic numerals in order of appearance in the text.
2) Figure Files
Although authors are encouraged to send the highest-quality figures possible, for peer-review purposes, a wide variety of formats, sizes, and resolutions are accepted. Click here for the basic figure requirements for figures submitted with manuscripts for initial peer review, as well as the more detailed post-acceptance figure requirements.
Figures submitted in color, if the manuscript is accepted for publication, may be reproduced in color online free of charge. Please note, however, that it is preferable that line figures (e.g., graphs and charts) are supplied in black and white so that they are legible if printed by a reader in black and white. If an author would prefer to have figures printed in colour in hard copies of the journal, a fee will be charged by the Publisher ($550 per figure).
3) Supporting Information
Supporting Information is information that is not essential to the article, but provides greater depth and background. It is hosted online and appears without editing or typesetting. It may include tables, figures, videos, datasets, etc. Click here for Wiley’s FAQs on Supporting Information.
Note: if data, scripts, or other artefacts used to generate the analyses presented in the paper are available via a publicly available data repository, authors should include a reference to the location of the material within their paper.
Article Preparation Support
Wiley Editing Services offers expert help with English Language Editing, as well as translation, manuscript formatting, figure illustration, figure formatting, and graphical abstract design – so you can submit your manuscript with confidence. Also, check out our resources for Preparing Your Article for general guidance about writing and preparing your manuscript.
5. EDITORIAL POLICIES AND ETHICAL CONSIDERATIONS
Editorial Review and Acceptance
The acceptance criteria for all papers are the quality and originality of the research and its significance to journal readership. Papers will only be sent to review if the Editor determines that the paper meets the appropriate quality and relevance requirements. Except where otherwise stated, manuscripts are single-blind peer reviewed. Wiley's policy on confidentiality of the review process is available here: www.wileypeerreview.com/reviewpolicy.
In some instances, if found to be unsuitable for publication in GLIA, the Editors may offer a referral to another neuroscience journal. GLIA's participation in transferable peer review programs is detailed in full elsewhere.
Conflicts of Interest
The journal requires that all authors disclose any potential sources of conflict of interest. Any interest or relationship, financial or otherwise that might be perceived as influencing an author's objectivity is considered a potential source of conflict of interest. These must be disclosed when directly relevant or directly related to the work that the authors describe in their manuscript. Potential sources of conflict of interest include, but are not limited to: patent or stock ownership, membership of a company board of directors, membership of an advisory board or committee for a company, and consultancy for or receipt of speaker's fees from a company. The existence of a conflict of interest does not preclude publication. If the authors have no conflict of interest to declare, they must also state this at submission. It is the responsibility of the corresponding author to review this policy with all authors and collectively to disclose with the submission ALL pertinent commercial and other relationships.
Funding
Authors should list all funding sources in the Acknowledgments section. Authors are responsible for the accuracy of their funder designation. If in doubt, please check the Open Funder Registry for the correct nomenclature: www.crossref.org/services/funder-registry.
Authorship
The list of authors should accurately represent who contributed to the work and how. Qualification for authorship is based on the following criteria. All listed authors should:
1) Have made substantial contributions to conception and design, or acquisition of data, or analysis and interpretation of data;
2) Been involved in drafting the manuscript or revising it critically for important intellectual content;
3) Have given final approval of the version to be published;
4) Have participated sufficiently in the work to take public responsibility for appropriate portions of the content; and
5) Have agreed to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Contributions from anyone who does not meet the criteria for authorship should be listed, with permission from the contributor, in an Acknowledgments section (for example, to recognize contributions from people who provided technical help, collation of data, writing assistance, acquisition of funding, or a department chairperson who provided general support).
Prior to submitting the manuscript, all authors should agree on the order in which their names will be listed in the manuscript.
Additional Authorship Options
Joint first or senior authorship: In the case of joint first authorship, a footnote should be added to the author listing, e.g. ‘X and Y should be considered joint first author’ or ‘X and Y should be considered joint senior author.’
Data Sharing and Data Accessibility
Please review Wiley’s policy here. GLIA expects but does not require data sharing.
All accepted manuscripts are required to publish a data availability statement to confirm the presence or absence of shared data. GLIA recognizes the many benefits of archiving research data. GLIA expects you to archive all the data from which your published results are derived in a public repository. The repository that you choose should offer you guaranteed preservation (see the registry of research data repositories at https://www.re3data.org/) and should help you make it findable, accessible, interoperable, and re-useable, according to FAIR Data Principles.
GLIA notes that FAIR data sharing allows for access to shared data under restrictions (e.g., to protect confidential or proprietary information) but notes that the FAIR principles encourage you to share data in ways that are as open as possible (but that can be as closed as necessary). If you have shared data, this statement will describe how the data can be accessed, and include a persistent identifier (e.g., a DOI for the data, or an accession number) from the repository where you shared the data. If you cannot share the data described in your manuscript, for example for legal or ethical reasons, or do not intend to share the data then you must provide the appropriate data availability statement. Sample statements are available here. If published, all statements will be placed in the heading of your manuscript.
ORCID
As part of the journal’s commitment to supporting authors at every step of the publishing process, the journal requires the submitting author (only) to provide an ORCID iD when submitting a manuscript. If the submitting author is not already registered with ORCiD, they can do so here: orcid.org/register; this takes around 2 minutes to complete. For more information, visit www.wileyauthors.com/orcid.
Publication Ethics
This journal is a member of the Committee on Publication Ethics (COPE). Note, this journal uses iThenticate’s CrossCheck software to detect instances of overlapping and similar text in submitted manuscripts. Read Wiley’s Top 10 Publishing Ethics Tips for Authors here: www.wileyauthors.com/ethics. Wiley’s Publication Ethics Guidelines can be found here.
6. EDITORIAL POLICIES AND ETHICAL CONSIDERATIONS
Accurate and complete reporting of scientific research results enables readers to fully appraise research, replicate it, and use it. Authors are encouraged to adhere to the relevant community-led research reporting standards, such as those listed here:
Consolidated Standards of Reporting Trials (CONSORT)
Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA)
PRISMA Protocols (PRISMA-P)
STrengthening the Reporting of OBservational studies in Epidemiology (STROBE)
CARE: Guidelines to increase the accuracy, transparency, and usefulness of case reports
STARD 2015: An Updated List of Essential Items for Reporting Diagnostic Accuracy Studies
TRIPOD: Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis
The EQUATOR Network: an author's one-stop-shop for writing and publishing high-impact health research
FORCE11: Recommended reporting guidelines for life science resources (see also the Resource Identification Initiative)
ARRIVE (Animal Research: Reporting of In Vivo Experiments) guidelines
Guidance for the Description of Animal Research in Scientific Publications from the US National Research Council's Institute for Laboratory Animal Research
The Gold Standard Publication Checklist from Hooijmans et al. (ATLA (2010) 38: 167–182)
Minimum Information Guidelines from Diverse Bioscience Communities (MIBBI)
Biosharing Standards
Resource Identification Initiative
The journal supports the Resource Identification Initiative, which aims to promote research resource identification, discovery, and reuse. This initiative, led by the Neuroscience Information Framework and the Oregon Health & Science University Library , provides unique identifiers for antibodies, model organisms, cell lines, and tools such as software and databases. These IDs, called Research Resource Identifiers (RRIDs), are machine-readable and can therefore be used to search for all papers in which a particular resource was used and to increase access to critical data to help researchers identify suitable reagents and tools.
Authors are asked to use RRIDs to cite the resources used in their research where applicable in the text, similar to a regular citation or Genbank Accession number. For antibodies, authors should include in the citation the vendor, catalogue number, and RRID both in the text upon first mention in the Methods section. For software tools and databases, please provide the name of the resource followed by the resource website, if available, and the RRID. For model organisms, the RRID alone is sufficient.
Additionally, authors must include the RIIDs in the list of keywords associated with the manuscript.
To Obtain Research Resource Identifiers (RRIDs):
Use the Resource Identification Portal, created by the Resource Identification Initiative Working Group.
Search for the research resource (please see the section titled “Search Features and Tips” for more information).
Click on the “Cite This” button to obtain the citation and insert the citation into the manuscript text.
If there is a resource that is not found within the Portal, authors are asked to register the resource with the appropriate resource authority. Information on how to do this is provided in the “Resource Citation Guidelines” section of the Portal.
If any difficulties in obtaining identifiers arise, please contact rii-help@scicrunch.org for assistance.
Example Citations:
Antibodies: “Wnt3 was localized using a rabbit polyclonal antibody C64F2 against Wnt3 (Cell Signaling Technology, Cat# 2721S, RRID: AB_2215411)”
Model Organisms: “Experiments were conducted in c. elegans strain SP304 (RRID:CGC_SP304)”
Cell lines: “Experiments were conducted in PC12 CLS cells (CLS Cat# 500311/p701_PC-12, RRID: CVCL_0481)”
Tools, Software, and Databases: “Image analysis was conducted with CellProfiler Image Analysis Software, V2.0 (www.cellprofiler.org, RRID: nif-0000-00280)”
Human Studies and Subjects
For manuscripts reporting medical studies that involve human participants, a statement identifying the ethics committee that approved the study and confirmation that the study conforms to recognized standards is required, for example: Declaration of Helsinki; US Federal Policy for the Protection of Human Subjects; or European Medicines Agency Guidelines for Good Clinical Practice.
Images and information from individual participants will only be published where the authors have obtained the individual's free prior informed consent. Authors do not need to provide a copy of the consent form to the publisher; however, in signing the author license to publish, authors are required to confirm that consent has been obtained. Wiley has a standard patient consent form available for use.
Animal Studies
A statement indicating that the protocol and procedures employed were ethically reviewed and approved, as well as the name of the body giving approval (e.g., institutional review board, independent ethics committee, ethical review board, or research ethics board), must be included in the Methods section of the manuscript. Authors are encouraged to adhere to animal research reporting standards, for example the ARRIVE Reporting Guidelines for reporting study design and statistical analysis; experimental procedures; experimental animals and housing and husbandry. Authors should also state whether experiments were performed in accordance with relevant institutional and/or national guidelines for the care and use of laboratory animals:
US authors should cite compliance with the US National Research Council's Guide for the Care and Use of Laboratory Animals, the US Public Health Service's Policy on Humane Care and Use of Laboratory Animals, and Guide for the Care and Use of Laboratory Animals.
UK authors should conform to UK legislation under the Animals (Scientific Procedures) Act 1986 Amendment Regulations (SI 2012/3039).
European authors outside the UK should conform to Directive 2010/63/EU.
Clinical Trial Registration
The journal requires that clinical trials are prospectively registered in a publicly accessible database. Clinical trial registration numbers should be included in all papers that report their results. Authors are asked to include the name of the trial register and the clinical trial registration number at the end of the abstract. If the trial is not registered, or was registered retrospectively, the reasons for this should be explained.
Sequence Data
Nucleotide sequence data can be submitted in electronic form to any of the three major collaborative databases: DDBJ, EMBL, or GenBank. It is only necessary to submit to one database as data are exchanged between DDBJ, EMBL, and GenBank on a daily basis. The suggested wording for referring to accession-number information is: ‘These sequence data have been submitted to the DDBJ/EMBL/GenBank databases under accession number U12345’. Addresses are as follows:
DNA Data Bank of Japan (DDBJ): www.ddbj.nig.ac.jp
EMBL Nucleotide Archive: www.ebi.ac.uk/ena
GenBank: www.ncbi.nlm.nih.gov/genbank
Proteins sequence data should be submitted to either of the following repositories:
Protein Information Resource (PIR): pir.georgetown.edu
SWISS-PROT: www.expasy.ch/sprot/sprot-top
7. AUTHOR LICENSING
If a paper is accepted for publication, the author identified as the formal corresponding author will receive an email prompting them to log in to Author Services, where via the Wiley Author Licensing Service (WALS) they will be required to complete a copyright license agreement on behalf of all authors of the paper.
Authors may choose to publish under the terms of the journal’s standard copyright agreement, or hybrid Open Access under the terms of a Creative Commons License.
General information regarding licensing and copyright is available here. To review the Creative Commons License options offered under hyrbid Open Access, please click here. (Note that certain funders mandate that a particular type of CC license has to be used; the Wiley Author Compliance Tool available at http://www.wileyauthors.com/compliancetool, provides assistance to authors in checking for any open-access mandates from their funder(s).)
Self-Archiving Definitions and Policies
Note that the journal’s standard copyright agreement allows for self-archiving of different versions of the article under specific conditions. For more detailed information about self-archiving definitions and policies, visit www.wileyauthors.com/self-archiving.
Open Access
Authors choosing to publish their article in an open-access format will be charged an Article Publication Charge (APC). A complete list of APCs for Wiley journals is available at www.wileyauthors.com/APCpricing.
For more information on Wiley’s compliance with the open-access policies of specific funders, visit www.wileyauthors.com/funderagreements.
8. PUBLICATION PROCESS AFTER ACCEPTANCE
Accepted Article Received in Production
Signing the License
When an accepted article is received by Wiley’s production team, the corresponding author will receive an email asking them to login or register with Wiley Author Services. The author will be asked to sign a publication license at this point. Further details are given in Section 6 of these Author Guidelines.
The Production Process
During the production process, the manuscript will be copyedited to apply house style and bring the text and graphics in line with the journal requirements. Very limited language polishing is carried out. To the best of their ability, authors should ensure their manuscript is free from typographical and grammatical errors.
Queries about the status of galley proofs or other matters relating to the production of an article from authors of accepted manuscripts should be directed to the Production Editor: jrnlprod.glia@cenveo.com
Proofs
Once the paper is typeset, the author will receive an email notification with the URL to download a PDF typeset page proof, as well as associated forms and full instructions on how to correct and return the file.
Please note that the author is responsible for all statements made in their work, including changes made during the editorial process – authors should check proofs carefully. Note that proofs should be returned within 48 hours of receipt.
Publication Charges
Color figures may be published online free of charge; however, the journal charges for publishing figures in colour in print. If the author supplies colour figures, they will be sent a Color Work Agreement once the accepted paper moves to the production process. If the Color Work Agreement is not returned by the specified date, figures will be converted to black and white for print publication.
Cover Illustrations
Authors of accepted manuscripts may submit artwork for consideration as cover illustrations; this should be done when providing final revised files for production purposes. The proposed cover illustration must be taken from among the figures from the manuscript, and the illustration should be in color.
Early View
The journal offers rapid publication via Wiley’s Early View service. Early View (Online Version of Record) articles are published on Wiley Online Library before inclusion in an issue. Note there may be a delay after corrections are received before the article appears online, as final changes are processed and the article prepared for online publication. Once the article is published on Early View, no further changes to the article are possible. The Early View article is fully citable and carries an online publication date and DOI for citations.
9. POST PUBLICATION
Access and Sharing
When an article is published online:
The author receives an email alert (if requested).
The link to the published article can be shared through social media.
The author will have free access to the paper (after accepting the Terms & Conditions of use, they can view the article).
The corresponding author and co-authors can nominate up to ten colleagues to receive a publication alert and free online access to their article.
Article Promotion Support
Wiley Editing Services offers professional video, design, and writing services to create shareable video abstracts, infographics, conference posters, lay summaries, and research news stories for your research – so you can help your research get the attention it deserves.
Measuring the Impact of an Article
Wiley also helps authors measure the impact of their research through specialist partnerships with Kudos and Altmetric.
10. JOURNAL CONTACT DETAILS
Author queries regarding submitted manuscripts under review or pre-submission queries should be directed to the Editorial Office (glia@u.washington.edu and glia.berlin@mdc-berlin.de). Author queries regarding accepted articles in production should be directed to the Production Editor (GLIAProd@wiley.com).
Author Guidelines updated December 4, 2020
